Latest Breaking News On - Sun yat sen university cancer center - Page 6 : vimarsana.com

Adding Fruquintinib to Paclitaxel Improves PFS in Gastric, GEJ Cancer

Fruquintinib plus paclitaxel could be a second-line treatment option for patients with gastric or gastroesophageal junction cancer, according to researchers. Fruquintinib plus paclitaxel could be a second-line treatment option for patients with gastric or GEJ cancer, according to researchers.

Rui hua xuSun yat sen university cancer center

Second-Line Fruquintinib Plus Paclitaxel Significantly Improves PFS But Not OS in Advanced Gastric or GEJ Adenocarcinoma

Fruquintinib/paclitaxel significantly improved PFS but not OS vs paclitaxel alone in the second-line treatment in patients with advanced gastric cancer.

Junshi biosciencesAstellas pharmaRui hua xuMerck seronoSun yat sen university cancer centerBristol myers squibbPhase 3 frutiga study nct03223376February 2024 asco plenary seriesPatients with advanced gastric or gastroesophageal junction adenocarcinoma

Mixed Results in Advanced Gastric/GEJ Cancer With Add-On Fruquintinib

Significant improvement in PFS, but not OS, versus chemo alone in the second-line setting

United statesFlorian lordickCharles bankheadRui hua xuAmerican society of clinical oncology plenary seriesSun yat sen university cancer centerUniversity cancer center leipzigAmerican societyClinical oncology plenaryMedpage today

Results of Phase II Study on Qilu Pharmaceutical s Novel Drug QL1706 Published in Signal Transduction and Targeted Therapy

/PRNewswire/ On January 29th, the results of the phase II study on Qilu Pharmaceutical s novel anticancer drug iparomlimab and tuvonralimab (QL1706) were.

Li zhangSun yat sen university cancer centerQilu pharmaceutical co ltdQilu pharmaceuticalSignal transductionTargeted therapyQilu pharmaceutical co

InnoCare Announces First Pediatric Patient Dosed in Clinical Trial of pan-TRK Inhibitor Zurletrectinib in China

InnoCare Announces First Pediatric Patient Dosed in Clinical Trial of pan-TRK Inhibitor Zurletrectinib in China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesChunhua luInnocare pharmaSun yat sen university cancer centerCare pharmaSun yat sen university cancer